Frontiers | ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion
Epidrugs in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia: Contextualizing a Role for Histone Kinase Inhibition in Neurodegenerative Disease | ACS Pharmacology & Translational Science
Clinical Controversies in Amyotrophic Lateral Sclerosis - European Medical Journal
Pathomechanism Heterogeneity in the Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disease Spectrum: Providing Focus Through the Lens of Autophagy - ScienceDirect
Amyotrophic Lateral Sclerosis–Frontotemporal Dementia | Neurology
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia - The Lancet Neurology
ALS Genes in the Genomic Era and their Implications for FTD: Trends in Genetics
Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington Disease | Neurology Genetics
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD - Pang - 2021 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease
Frontiers | Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation | Nature Reviews Drug Discovery
IJMS | Free Full-Text | TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Taylor & Francis Online
Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism - The Lancet Neurology
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline | Molecular Neurodegeneration | Full Text
FTD and ALS—translating mouse studies into clinical trials | Nature Reviews Neurology
Structural Features of Small Molecules Targeting the RNA Repeat Expansion That Causes Genetically Defined ALS/FTD | ACS Chemical Biology
Story of the ALS-FTD continuum retold: rather two distinct entities | Journal of Neurology, Neurosurgery & Psychiatry
Biomedicines | Free Full-Text | Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
